Should James Hardie Industries plc be on your buy list?

Lower interest rates should spur on housing related stocks, but does James Hardie Industries plc (ASX:JHX) have some headwinds against it?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The housing industry is basically the only bright spot in the Australian economy, fuelled by record low interest rates that might just go lower. If the RBA sets cash target rates to 2% or even lower to pump prime business growth, that will spur on more housing construction.

Likewise, the U.S. housing market is making a recovery. The U.S. Federal Reserve Bank may have stopped its quantitative easing (QE), but there interest rates are also being kept really low to stimulate the economy.

There is one Australian company with significant business both here and in the U.S. that investors should know about.

James Hardie Industries plc (ASX: JHX) is known for its fibre cement housing construction products like Hardiplank used for siding, panels and roofing. The company is seeing improvement in its second quarter of FY 2015. Group net sales were up 12% and adjusted net operating profit rose 16% due to higher earnings margins.

That helped pull up half-year results with interim adjusted net operating profit up 7%. Housing starts, a leading indicator of construction, are still low in the U.S. compared to pre-GFC levels, but that could improve over the next several years since U.S. GDP is rising close to 3%.

About 74% of the company's revenue is from the U.S. and Australia accounts for around 17%, so it stands to benefit over the mid-term as both countries are keeping interest rates as accommodating as possible. The stock pays a decent 3.2% yield and its price-earnings to growth (PEG) ratio is astonishingly low.

This is surprising since consensus earnings growth forecasts indicate very high double-digit annual growth over the next two years. This could be because investors may not be convinced the U.S. housing market will improve so well. It could also be partly from the compensation payments it must make to people who have asbestos-related illness due to exposure to the company's older products.

Although James Hardie does have some interesting prospects, I am not quite convinced that this is the time to go heavily into it. As a cyclical stock, even though revenue and earnings may continue to rise, early investors may move on to other industries if they think the housing industry is close to a cyclical peak.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »